- Trials with a EudraCT protocol (368)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
368 result(s) found for: Energy.
Displaying page 1 of 19.
EudraCT Number: 2018-000029-29 | Sponsor Protocol Number: 95105003 | Start Date*: 2018-12-11 |
Sponsor Name:VU University Medical Center | ||
Full Title: Extra energy for hearts with a genetic defect: ENERGY trial | ||
Medical condition: Hypertrophic cardiomyopathy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001762-13 | Sponsor Protocol Number: sepsis 1 | Start Date*: 2005-07-13 |
Sponsor Name:Universitätskinderklinik Heidelberg | ||
Full Title: Energy metabolism of critically ill children treated with lipid emulsion and carnitine | ||
Medical condition: The primary purpose of the study is an examination of the ability of lipid emulsions and carnitin supplementation to reduce the morbidity associated with sepsis and catabolic conditions by altering... | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-003850-21 | Sponsor Protocol Number: InflaMed001 | Start Date*: 2022-08-03 |
Sponsor Name:Amsterdam UMC, location VUmc | ||
Full Title: Precision psychiatry: Anti-inflammatory medication in Immuno-metabolic depression | ||
Medical condition: Immuno metabolic Depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000530-54 | Sponsor Protocol Number: VS56151/17000277 | Start Date*: 2018-01-16 | |||||||||||||||||||||
Sponsor Name:University of Copenhagen | |||||||||||||||||||||||
Full Title: The effect of cannibinols in patients with pancreatic cancer in the palliative state | |||||||||||||||||||||||
Medical condition: Pancreatic cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019899-77 | Sponsor Protocol Number: dx3 | Start Date*: 2010-06-21 | ||||||||||||||||||||||||||
Sponsor Name:Mette Astrup Madsen | ||||||||||||||||||||||||||||
Full Title: Can preoperative Dexamethasone optimise surgical outcomes after laparoscopic inguinal hernia repair. | ||||||||||||||||||||||||||||
Medical condition: Postoperative pain, nausea, vomiting, general well-being and convalescence after laparoscopic groin hernia repair. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008065-35 | Sponsor Protocol Number: TYNERGY | Start Date*: 2009-03-13 | ||||||||||||||||
Sponsor Name:BiogenIdec A/S | ||||||||||||||||||
Full Title: A multi-centre and prospective trial to evaluate the effects on mul-tiple sclerosis related fatigue during treatment with Tysabri® in patients with relapsing remitting multiple sclerosis over the c... | ||||||||||||||||||
Medical condition: Mutiple sclerosis related fatigue in subjects with relapsing remitting multiple sclerosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002080-88 | Sponsor Protocol Number: NA | Start Date*: 2005-09-13 | |||||||||||
Sponsor Name:Aintree Hospitals NHS Trust and University of Liverpool | |||||||||||||
Full Title: A double−blind, placebo−controlled crossover trial to quantify the effects of sibutramine on energy intake and energy expenditure in obese subjects during a test meal | |||||||||||||
Medical condition: Obesity defined as BMI > 30 kg /m2 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004866-16 | Sponsor Protocol Number: I5E-MC-TSAT | Start Date*: 2013-06-06 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Parallel Study with an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men. | |||||||||||||
Medical condition: Male hypogonadism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023996-25 | Sponsor Protocol Number: 26081985 | Start Date*: 2010-12-21 |
Sponsor Name: | ||
Full Title: The effect of fluoxetine and 5-HT4 serotonin receptor agonists on cerebral axonal energy metabolism and glutamate levels in multiple sclerosis. | ||
Medical condition: Multiple sclerosis (both relapsing remitting and progressive forms) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005578-39 | Sponsor Protocol Number: PKI108574 | Start Date*: 2007-01-18 | |||||||||||
Sponsor Name:GlaxoSmithKline | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled study to explore the antidepressant properties of the P38a kinase inhibitor GW856553X 15mg compared to placebo in subjects with Major Depressive Disor... | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006424-18 | Sponsor Protocol Number: EC/2006/117/PGMS | Start Date*: 2007-03-01 | |||||||||||
Sponsor Name:University of Surrey | |||||||||||||
Full Title: THE EFFECT OF RIMONABANT ON ENERGY EXPENDITURE, FATTY ACID METABOLISM, TRIACYLGLYCEROL METABOLISM AND BODY FAT DISTRIBUTION | |||||||||||||
Medical condition: Obesity | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002376-95 | Sponsor Protocol Number: RRK3535 | Start Date*: 2009-01-05 |
Sponsor Name:University Hospital Birmingham NHS Foundation Trust | ||
Full Title: Myocardial protection with Perhexiline in Left Ventricular Hypertrophy | ||
Medical condition: Patients with left ventricular hypertrophy undergoing aortic valve surgery (with or without coronary artery surgery) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002520-16 | Sponsor Protocol Number: 626 | Start Date*: 2007-07-06 | |||||||||||
Sponsor Name:Universitätsklinik für klinische Pharmakologie, Medizinische Universität Wien | |||||||||||||
Full Title: The effects of post-conditioning and administration of Vitamin C on intramuscular high energy phosphate levels | |||||||||||||
Medical condition: ischemia reperfusion injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002487-41 | Sponsor Protocol Number: GLY-321-2017 | Start Date*: 2018-01-31 | |||||||||||
Sponsor Name:GLyPharma Therapeutic Inc. (a wholly owned subsidiary of VectivBio Holding AG) | |||||||||||||
Full Title: A Phase Ib/IIa open-label, repeated dose, metabolic balance study of FE 203799 in patients with short bowel syndrome | |||||||||||||
Medical condition: Short bowel syndrome (SBS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002720-27 | Sponsor Protocol Number: 2014-002720-27 | Start Date*: 2014-12-04 |
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | ||
Full Title: Simplification from Tenofovir plus Lamivudine or Emtricitabine plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir plus Lamivudine in Virologically-Suppressed-HIV-Infected Adu... | ||
Medical condition: Chronic HIV infection. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005112-42 | Sponsor Protocol Number: C14-62 | Start Date*: 2015-06-22 | |||||||||||
Sponsor Name:INSERM | |||||||||||||
Full Title: A comparative phase2 study assessing the efficacy of triheptanoin, an anaplerotic therapy in Huntington's Disease (TRIHEP 3) | |||||||||||||
Medical condition: Huntington's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000238-23 | Sponsor Protocol Number: ExeBAT01 | Start Date*: 2016-08-09 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: The effect of Exenatide on brown adipose tissue activity and energy expenditure in healthy young men | ||
Medical condition: Healthy volunteers, intended indications: obesity and dyslipidemia | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-009155-37 | Sponsor Protocol Number: 2008/066/HP | Start Date*: 2010-09-07 |
Sponsor Name:CHU-HOPITAUX DE ROUEN | ||
Full Title: Evaluation of the impact of physical reconditioning associated with specific nutritional supplementation in obese patients suffering of metabolic syndrome. | ||
Medical condition: Obese patients suffering of metabolic syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002512-27 | Sponsor Protocol Number: NL44774.068.13 | Start Date*: 2013-11-25 |
Sponsor Name:Maastricht University | ||
Full Title: The role of bile acids in human brown adipose tissue metabolism | ||
Medical condition: Healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015771-27 | Sponsor Protocol Number: V3 | Start Date*: 2010-01-21 |
Sponsor Name:Medizinische Universität Wien, Univ.Klinik für Notfallmedizin | ||
Full Title: Requirement of Skeletal Muscle Paralysis in Hypothermic Patients after Cardiac Arrest. A pilot study | ||
Medical condition: skeletal muscle paralysis in hypothermic patients after cardiac arrest | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.